Fighting Blindness Canada research

Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial

Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...

Read More
Fighting Blindness Canada

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr Eric Pierce and Dr Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for...

Read More
Fighting Blindness Canada

Stargardt Disease

Stargardt disease is a rare genetic eye disease that happens when fatty material builds up on the macula Vision loss usually starts in...

Read More
Fighting Blindness Canada research

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa Beacon...

Read More
Fighting Blindness Canada

Clinical Trial Launched to Test New Drug for AMD and DME

Fighting Blindness Canada funded researcher Dr Sachdev Sidhu (University of Waterloo) has developed a novel antibody therapy that will now be tested...

Read More
1 4 5 6 7 8 51